First Bellwether Trial in Xarelto MDL Ends in Defense Verdict



DOCUMENTS
  • Verdict


NEW ORLEANS — The first bellwether trial in the Xarelto federal multidistrict litigation has ended with a defense verdict in favor of defendants Janssen Pharmaceuticals Inc., Janssen Research & Development LLC, Janssen Ortho LLC, Johnson & Johnson, Bayer Pharma AG, and Bayer Healthcare Pharmaceuticals Inc., HarrisMartin Publishing is reporting.

In a verdict reached moments ago, the U.S. District Court for the Eastern District of Louisiana jury found defendants did not fail to adequately warn plaintiff Joseph Boudreaux’s prescribing doctor and, as such, the failure-to-warn claims are barred by the learned intermediary doctrine.

Boudreaux, 74, of Lockport, La., alleged he developed …






UPCOMING CONFERENCES




HarrisMartin's Masters of Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS



HarrisMartin's Webinar Series: Video Game Addiction Product Liability Litigation

March 29, 2024

MORE DETAILS